María Pilar
Garrido López
Profesor/a Asociado/a en CC. de la Salud
KU Leuven
Lovaina, BélgicaPublicaciones en colaboración con investigadores/as de KU Leuven (7)
2022
-
Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management
Virchows Archiv, Vol. 481, Núm. 3, pp. 335-350
-
Expert opinion on NSCLC small specimen biomarker testing — Part 2: Analysis, reporting, and quality assessment
Virchows Archiv, Vol. 481, Núm. 3, pp. 351-366
-
The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series
ESMO Open, Vol. 7, Núm. 1
2021
-
The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II
ESMO open, Vol. 6, Núm. 4, pp. 100199
-
The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration
ESMO open, Vol. 6, Núm. 2, pp. 100058
2020
-
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma
Investigational New Drugs, Vol. 38, Núm. 2, pp. 457-467
2017
-
Selumetinib plus docetaxel compared with docetaxel alone and progression-free survival in patients with KRAS-mutant advanced non-small cell lung cancer: The SELECT-1 randomized clinical trial
JAMA - Journal of the American Medical Association, Vol. 317, Núm. 18, pp. 1844-1853